Polylactide Perspectives in Biomedicine: From Novel Synthesis to the Application Performance

The incessant developments in the pharmaceutical and biomedical fields, particularly, customised solutions for specific diseases with targeted therapeutic treatments, require the design of multicomponent materials with multifunctional capabilities. Biodegradable polymers offer a variety of tailored physicochemical properties minimising health adverse side effects at a low price and weight, which are ideal to design matrices for hybrid materials. PLAs emerge as an ideal candidate to develop novel materials as are endowed withcombined ambivalent performance parameters. The state-of-the-art of use of PLA-based materials aimed at pharmaceutical and biomedical applications is reviewed, with an emphasis on the correlation between the synthesis and the processing conditions that define the nanostructure generated, with the final performance studies typically conducted with either therapeutic agents by in vitro and/or in vivo experiments or biomedical devices.

Aluminium complexes of salanol ligands: coordination chemistry and stereoselective lactide polymerization

Aluminium complexes of the new salanol ligands give rise to all PLA tacticities by different stereocontrol mechanisms.

Synthesis and stereocomplex formation of enantiomeric alternating copolymers with two types of chiral centers, poly(lactic acid-alt-2-hydroxybutanoic acid)s

Stereocomplex (SC) formation was reported for the first time for enantiomeric alternating copolymers consisting of repeating units with two types of chiral centers, poly(lactic acid-alt-2-hydroxybutanoic acid)s [P(LA-alt-2HB)s]. l,l-Configured poly(l-lactic acid-alt-l-2-hydroxybutanoic acid) [P(LLA-alt-l-2HB)] and d,d-configured poly(d-lactic acid-alt-d-2-hydroxybutanoic acid) [P(DLA-alt-d-2HB)] were amorphous. Blends of P(LLA-alt-l-2HB) and P(DLA-alt-d-2HB) were crystallizable and showed typical SC-type wide-angle X-ray diffraction profiles similar to those reported for stereocomplexed blends of poly(l-lactic acid) and poly(d-lactic acid) homopolymers and of poly(l-2-hydroxybutanoic acid) and poly(d-2-hydroxybutanoic acid) homopolymers, and of l,l-configured poly(l-lactic acid-co-l-2-hydroxybutanoic acid) [P(LLA-co-l-2HB)] and d,d-configured poly(d-lactic acid-co-d-2-hydroxybutanoic acid) [P(DLA-co-d-2HB)] random copolymers. The melting temperature values and melting enthalpy values at 100% crystallinity for stereocomplexed solvent-evaporated and precipitated P(LLA-alt-l-2HB)/P(DLA-alt-d-2HB) blends were correspondingly 187.5 and 187.9 °C, and 98.1 and 91.8 J g⁻¹. Enantiomeric polymer blending of P(LLA-alt-l-2HB) and P(DLA-alt-d-2HB) can confer crystallizability by stereocomplexation and the biodegradable materials with a wide variety of physical properties and biodegradability are highly expected to be prepared by synthesis of alternating copolymers of various combinations of two types of chiral α-substituted 2-hydroxyalkanoic acid monomers and their SC crystallization.

Stereocomplex formation was reported for alternating copolymers of chiral α-substituted 2-hydroxyalkanoic acids which can be utilized for preparation of biodegradable materials with a variety of physical properties and biodegradability.

Stereocomplexes of Discrete, Isotactic Lactic Acid Oligomers Conjugated with Oligodimethylsiloxanes

Discrete length block co-oligomers (BCOs) comprised of a crystalline and an amorphous block are a new class of materials that gives highly ordered lamellar morphologies at small length scales. Here, we show the preparation of discrete, isotactic oligo l- and d-lactic acid (olLA and odLA) homoblocks followed by ligation to oligodimethylsiloxane (oDMS), affording a library of crystalline-amorphous BCOs that vary in molecular weight and composition. Mixing the two enantiomeric BCOs or homoblocks results in the formation of the corresponding stereocomplex. The properties and phase behavior of the isotactic (block co)oligomers and the stereocomplexes thereof are studied using differential scanning calorimetry and small-angle X-ray scattering. A systematic study of the isotactic homoblock lengths and crystal structure confirmed the formation of a 103 helix with a monomeric rise of 0.3 nm, whereas the stereocomplex adopts a 31 helix. The same type of crystal structure was found for the isotactic and stereocomplex of BCOs giving rise to the formation of lamellar morphologies at room temperature as a result of crystallization of the oLA blocks. Distorted lamellar structures were found in BCOs that preorganize into nonlamellar morphologies prior to crystallization. The stereocomplex BCOs shows more crystal defects and a loss of long-range ordering in the microstructure due to the larger driving force for crystallization. Hence, the balance between chain length, block volume, and the crystallization strength are of major importance for the formation of the final structure with the least defects.

Stereocomplex-affected crystallization behaviour of PDLA in PDLA/PLDLA blends

In the presence of SC crystals, the spherulite growth rate of PDLA decreased, whereas its overall crystallization rate increased.

Stereocomplexation of cyclic polylactides with each other and with linear poly(l-lactide)s

This study describes for the first time syntheses and properties of stereocomplexes based on cyclic polylactides.